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Determine mechanisms by which CLA reduces adipose 
mass in mice


























Experimental design.  6-week old, male B6.V-Lepob/OlaHsd (ob/ob) mice were obtained through Harlan (Indianapolis,
IN) and housed 4/cage at 22oC ± 0.5oC on a 12-hour light/dark cycle.  Mice were maintained on isocaloric, modified AIN-
93G diets (Bio-Serv, Frenchtown, NJ) containing 6.5% fat.  Mice received diets that contained either 6.5% soybean oil 
(CON; n=8) or 5% soybean oil and 1.5% CLA mixed triglycerides (CLA; n=8).  CLA mixed triglycerides (Tonalin TG 80, 
Cognis Corp., Cincinnati, OH) were ~80% CLA composed of 39.2% c9t11- and 38.5% t10c12-CLA isomers. At 4 weeks, 
after an overnight (12 hr) fast, mice were anesthetized with isoflurane and blood was collected via cardiac puncture. Tissues 
were quickly harvested, weighed, snap-frozen with liquid nitrogen, and stored at -80oC until analyses.  All procedures were 
in accordance with institution guidelines and approved by the Institutional Animal Care and Use Committee of The Ohio 
State University.
Analysis of triglycerides and free fatty acids. Serum free fatty acids were determined using a colorimetric kit (NEFA C, 
Wako Chemicals, Richmond, VA).  Lipids were extracted from tissues with 2:1 (v/v) chloroform and methanol.  Final 
extracts were solublized in 3:1:1 (v/v/v) tert-butanol, methanol, Trition X-100 (4).  Tissue lipid extracts and serum were 
analyzed for triglycerides or glycerol by colorimetric enzymatic hydrolysis (Triglyceride, Free-Glycerol reagents, Sigma, 
St. Louis, MO). 
Real-time RT-PCR. RNA was extracted from epididymal adipose tissue using the RNeasy® Lipid Tissue Mini kit 
(Qiagen, Valencia, CA) and from liver using Trizol (Invitrogen, Carlsbad, CA) according to manufacturers’ protocols. 
RNA was reverse transcribed with High Capacity cDNA Archive Kit (ABI, Foster City, CA) according to directions and 
then amplified by real-time PCR using pre-designed and validated primers (FAM probes) under universal cycling 
conditions defined by ABI (TaqMan Gene Expression Assays, ABI, Foster City, CA).  Target gene expression was 
normalized to the endogenous control 18s (VIC probe) amplified in the same reaction and expressed as 2-∆∆ct relative to the 
CON group (5).
Western blot analysis. Adipose tissue was homogenized in 3 volumes of ice cold lysis buffer (20 mM Trizma base, 50mM 
NaCl, 250 mM sucrose, 50 mM NaF, 5 mM Na4P2O7 . 10H2O, 1% Triton-X100, and protease inhibitors).  Protein 
concentrations were measured by the BCA method (Pierce, Rockford, IL).   Protein (40 µg) was mixed and boiled for 5 min 
with 4X loading buffer (125 mM Tris HCl at pH 6.8, 50% glycerol, 4% SDS, 0.02% Bromophenol Blue) and β-
mercapatoethanol and subjected to SDS-PAGE using 10% gels for 1 h.  Protein was then transferred to nitrocellulose 
membranes for 1 h on ice.  Membranes were probed for P-AMPK (Cell Signaling Technology, Inc., Danvers, MA) 
according to manufacturer’s protocol. Membranes were incubated in SuperSignal West Femto Maximum Sensitivity 
Substrate (Pierce, Rockford, IL) for 5 min.  Densities of bands were detected and measured by Kodak ImageStation
2000RT using 1D Kodak software.  Membranes were stripped with RestoreTM Western Blot Stripping Buffer (Pierce, 
Rockford, IL) for 30 min at RT and reprobed with total-AMPK (Cell Signaling).
Statistical analyses. Data are expressed as means ± standard error (SE).  Effects of diet were analyzed by 2-sample t-test 
(Minitab v.14, State College, PA). Differences of P<0.05 were considered significant. 
Conjugated linoleic acid (CLA) (rev. in 1)
• Positional and stereo-isomers of octadecadienoic acid (18:2)
• Found naturally in foods derived from ruminants
• Reduces adipose mass in a variety 
of species
• mediated by the t10c12 isomer
• Commercially marketed as a weight 
loss supplement (eg. Tonalin™)
• Mechanism by which CLA reduces 
adipose mass is not completely understood
Uncoupling protein 1 (Ucp1) (rev. in 2)
•Uncouples mitochondria creating an energy leak that “pulls” fatty acids                       
through the mitochondria
•Peroxisome proliferator-activated receptor gamma coativator 1alpha (PGC-
1alpha) increases Ucp1 transcription
AMP-activated protein kinase (AMPK) (rev. in 3)
•Increases PGC1a and Ucp1 expression
•Increased energy expenditure
•Increases fatty acid oxidation:
P-AMPK:
•Phosphorylates acetyl-coA carboxylase (ACC) inactivating the enzyme
•ACC:  rate limiting step in malonyl-CoA synthesis
•Decreased malonyl-CoA relieves inhibition of Cpt1
•Cpt1:  rate limiting step in Β-oxidation
•Increased B-oxidation
Conjugated linoleic acid (CLA) is a group of polyunsaturated fatty acid isomers 
found naturally in ruminant products such as milk and beef.  CLA reduces body 
weight and adipose mass in a variety of species.  However, the mechanism by 
which CLA depletes adipose mass is unclear.  Therefore, the objective of this 
study is to determine how CLA reduces adipose mass.  6-week old, male ob/ob 
mice were fed either a control diet (CON) or a diet supplemented with 1.5% 
mixed isomer CLA (CLA) for 4 weeks.  CLA significantly reduced body weight 
(28.98 g vs. 42.20 g) and epididymal adipose mass (1.71 g vs. 2.96 g) compared 
to CON.  While CLA generally induces hepatic steatosis in mice, which may 
account for some of the fat mobilization, here, neither liver nor muscle 
triglycerides were affected by CLA.  Similarly, no markers of lipid oxidation, 
such as Cpt-1, Ppara, or Acox1 mRNA, were altered by CLA in the liver or 
muscle.  Notably, these markers of lipid oxidation were not altered or reduced by 
CLA in adipose tissue.  CLA did, however, increase activation of AMP-kinase
(AMPK), an energy sensor that, when activated, increases β-oxidation.  
Interestingly, mRNA expression of Ucp1, a mitochondrial protein involved in 
energy dissipation, was increased ~109-fold by CLA.  Concomitantly, CLA 
increased mRNA expression of Pgc1a, a cofactor important in the upregulation
of Ucp1 and mitochondrial biogenesis, nearly 2.5-fold.  These data suggest that 
CLA may reduce adipose mass by increasing β-oxidation through increased 
activation of AMPK and increased energy dissipation by Ucp1 in adipose.
Conjugated linoleic acid increases Ucp1 
and activated AMPK in adipose tissue
Angela A. Wendel, Aparna Purushotham, Li-Fen Liu, and Martha A. Belury. 








0.60 ± 0.03*1.07 ± 0.11Adipose HSL mRNA expression
1.03 ± 0.061.05 ± 0.11Adipose ATGL mRNA expression
36.86 ± 4.4856.96 ± 9.74Serum glycerol (mg/dl)
1.03 ± 0.110.90 ± 0.07Serum NEFA (mEq/L)
131.42 ± 16.8688.13 ± 11.71Serum triglyceride (mg/dl)
CLACON
1.71 ± 0.14*2.96 ± 0.17Adipose (g)
69.08 ± 8.6081.40 ± 7.90Gastrocnemius muscle (g)
173.31 ± 11.2172.91 ± 18.64Liver triglycerides (mg TG/ g tissue)
39.4 ± 5.2052.52 ± 7.11Muscle triglycerides (mg TG/ g tissue)
3.18 ± 0.282.76 ± 0.18Liver (g)















































































Table 1.  Effects of CLA on body and tissue weights and tissue triglycerides.
CLA did not increase markers of lipolysis
Table 2.  Effects of CLA on markers of lipolysis.
* Values represent means ± SE with significant differences from CON (p<0.05) denoted by *
CLA increased FA transport into adipose, but did not alter mRNA markers 
of oxidation or lipogenesis
Fig. 1. CLA does not alter mRNA 
markers of oxidation or lipogenesis in 
adipose. Mice were fed either control 
(CON) or CLA-supplemented (CLA) diets.  
After 4 weeks, mRNA was measured from 
adipose of fasted mice by real time RT-
PCR. Values represent means ± SE with 
significant differences from CON (p<0.05) 
denoted by *
CLA increased Ucp1 and PGC1α mRNA expression in adipose
Fig. 2. CLA increased Ucp1 and PGC1α expression in adipose. Mice were fed either control (CON) or 
CLA-supplemented (CLA) diets.  After 4 weeks, A. Ucp1 or B. Pgc1α mRNA was measured from adipose of 
fasted mice by real time RT-PCR. Values represent means ± SE with significant differences from CON 
(p<0.05) denoted by *
* *
CLA reduced body and adipose weights, 
but did not divert lipid to other tissues
* Values represent means ± SE with significant differences from CON (p<0.05) denoted by *
CLA increased activated AMPK in adipose
*
Fig. 3. CLA increases activated 
(phosporylated) AMPK in adipose. Mice 
were fed either control (CON) or CLA-
supplemented (CLA) diets.  After 4 weeks, 
P-AMPK and total-AMPK were measured 
from adipose of fasted mice by Western 
blot analysis. Values represent means ± 
SE with significant differences from CON 
(p<0.05) denoted by *
A B
Conclusions
CLA may reduce adipose mass through increased energy dissipation (Ucp1 & Pgc1α) 
and increased activation of AMPK, which would relieve inhibition of Cpt1, thus 
increasing B-oxidation in adipose.
Research to determine the mechanism by which CLA increases Ucp1, Pgc1α, and P-
AMPK are currently being investigated.
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